Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alloimmunization as a strategy for vaccine design against HIV/AIDS.

× No keyword cloud information.

13 in total

1. Inhibition of human immunodeficiency virus type 1 infection of human CD4+ T cells by microbial HSP70 and the peptide epitope 407-426.

Authors: Kaboutar Babaahmady; Wulf Oehlmann; Mahavir Singh; Thomas Lehner
Journal: J Virol Date: 2007-01-24 Impact factor: 5.103

2. The Trojan exosome hypothesis.

Authors: Stephen J Gould; Amy M Booth; James E K Hildreth
Journal: Proc Natl Acad Sci U S A Date: 2003-08-28 Impact factor: 11.205

Review 3. Targeting Trojan Horse leukocytes for HIV prevention.

Authors: Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal: AIDS Date: 2010-01-16 Impact factor: 4.177

4. Working group consultation: alloimmunity as a vaccine approach against HIV/AIDS: National Institutes of Health Meeting Report, May 24, 2012.

Authors: Anjali Singh; Jon Warren; Alan Schultz; Charles J Hackett; Opendra Sharma
Journal: AIDS Res Hum Retroviruses Date: 2013-04-23 Impact factor: 2.205

5. Cytoskeletal proteins bound to heat-shock protein 70 may elicit resistance to simian immunodeficiency virus infection of CD4(+) T cells.

Authors: Lesley A Bergmeier; Kaboutar Babaahmady; Jeffrey Pido-Lopez; Kate J Heesom; Charles G Kelly; Thomas Lehner
Journal: Immunology Date: 2009-11-25 Impact factor: 7.397

6. Prior mucosal exposure to heterologous cells alters the pathogenesis of cell-associated mucosal feline immunodeficiency virus challenge.

Authors: Surender B Kumar; Sarah Leavell; Kyle Porter; Barnabe D Assogba; Mary J Burkhard
Journal: Retrovirology Date: 2010-05-28 Impact factor: 4.602

7. Quantitation of HLA proteins incorporated by human immunodeficiency virus type 1 and assessment of neutralizing activity of anti-HLA antibodies.

Authors: Samir K Lakhashe; Madhuri R Thakar; K E Bharucha; Ramesh S Paranjape
Journal: J Virol Date: 2007-10-17 Impact factor: 5.103

8. Allo-immunization elicits CCR5 antibodies, SDF-1 chemokines, and CD8-suppressor factors that inhibit transmission of R5 and X4 HIV-1 in women.

Authors: Y Wang; J Underwood; R Vaughan; A Harmer; C Doyle; T Lehner
Journal: Clin Exp Immunol Date: 2002-09 Impact factor: 4.330

9. Alloantigen-based AIDS vaccine: revisiting a "rightfully" discarded promising strategy.

Authors: Gene M Shearer; Adriano Boasso
Journal: F1000 Med Rep Date: 2011-06-01

10. Greater ethnic diversity correlates with lower HIV prevalence in Africa: justification for an alloimmunity vaccine.

Authors: Christopher Zamani; Jared D Elzey; James Ek Hildreth
Journal: HIV AIDS (Auckl) Date: 2013-04-12